Gene · 28402
Papers3,091
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,161 to 1,180 of 3,091
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evaluation of Somatic Hypermutation Status in Chronic Lymphocytic Leukemia (CLL) in the Era of Next Generation Sequencing. | Front Cell Dev Biol | 2020 | 32509784 | PubTator, text mining | PubMed |
| The regulation and function of CD20: an "enigma" of B-cell biology and targeted therapy. | Haematologica | 2020 | 32482755 | PubTator, text mining | PubMed |
| Mechanisms of B Cell Receptor Activation and Responses to B Cell Receptor Inhibitors in B Cell Malignancies. | Cancers (Basel) | 2020 | 32481736 | PubTator, text mining | PubMed |
| Ibrutinib Resistance Mechanisms and Treatment Strategies for B-Cell lymphomas. | Cancers (Basel) | 2020 | 32455989 | PubTator, text mining | PubMed |
| Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphoma. | Nat Commun | 2020 | 32424289 | PubTator, text mining | PubMed |
| UGT2B17 modifies drug response in chronic lymphocytic leukaemia. | Br J Cancer | 2020 | 32418995 | PubTator, text mining | PubMed |
| Identification of Human Single-Domain Antibodies against SARS-CoV-2. | Cell Host Microbe | 2020 | 32413276 | PubTator, text mining | PubMed |
| Expression Profiling and Cell Type Classification Analysis in Periodontitis Reveal Dysregulation of Multiple lncRNAs in Plasma Cells. | Front Genet | 2020 | 32411181 | PubTator, text mining | PubMed |
| Survey of ex vivo drug combination effects in chronic lymphocytic leukemia reveals synergistic drug effects and genetic dependencies. | Leukemia | 2020 | 32404973 | PubTator, text mining | PubMed |
| Treatment algorithm for Japanese patients with chronic lymphocytic leukemia in the era of novel targeted therapies. | J Clin Exp Hematop | 2020 | 32404571 | PubTator, text mining | PubMed |
| Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with the BTK inhibitor zanubrutinib: phase 2, single-arm, multicenter study. | J Hematol Oncol | 2020 | 32393328 | PubTator, text mining | PubMed |
| Celebrating 20 Years of IGHV Mutation Analysis in CLL. | Hemasphere | 2020 | 32382709 | PubTator, text mining | PubMed |
| RNA Editing Alters miRNA Function in Chronic Lymphocytic Leukemia. | Cancers (Basel) | 2020 | 32380696 | PubTator, text mining | PubMed |
| Polymorphisms in human immunoglobulin heavy chain variable genes and their upstream regions. | Nucleic Acids Res | 2020 | 32365177 | PubTator, text mining | PubMed |
| DNA methylation of chronic lymphocytic leukemia with differential response to chemotherapy. | Sci Data | 2020 | 32358561 | PubTator, text mining | PubMed |
| CD4+ T Cells in the Blood of MS Patients Respond to Predicted Epitopes From B cell Receptors Found in Spinal Fluid. | Front Immunol | 2020 | 32328067 | PubTator, text mining | PubMed |
| Loxoscelism: Advances and Challenges in the Design of Antibody Fragments with Therapeutic Potential. | Toxins (Basel) | 2020 | 32316084 | PubTator, text mining | PubMed |
| Prognostic markers in Chronic Lymphocytic Leukaemia - A flow cytometric analysis. | Pak J Med Sci | 2020 | 32292430 | PubTator, text mining | PubMed |
| Adjuvant herbal therapy for targeting susceptibility genes to Kawasaki disease: An overview of epidemiology, pathogenesis, diagnosis and pharmacological treatment of Kawasaki disease. | Phytomedicine | 2020 | 32283413 | PubTator, text mining | PubMed |
| Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis beyond the CLL international prognostic index. | Am J Hematol | 2020 | 32279347 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28402/papers?page=59